NPI-002 Intravitreal Implant

NPI-002 intravitreal implant · Nacuity Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NPI-002 Intravitreal Implant, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: NPI-002 Intravitreal Implant for the Delay of Cataract Progression [Phase 1, Phase 2]